Newspaper wrap-up 4-4-07: AstraZeneca may lose 38% of its revenue in next 5 years
Posted Apr 4th 2007 9:20AM by Eric Buscemi
Filed under: Newspapers, Magazines, Best Buy (BBY), Boeing Co (BA), Circuit City Stores (CC), Hershey Co (HSY), Wrigley, (Wm) Jr (WWY)
MAJOR PAPERS:
OTHER PAPERS:
- According to the U.K. Times, citing research by Prudential Equity Group and AXA Framlington, AstraZeneca (NYSE: AZN) could lose 38% of its revenue because key drug patents, including Arimi-dex, Seroquel and Symbicort, will expire in the next five years.
- Investor's Business Daily's "The New America" column mentioned Israeli defense firm Elbit Systems Ltd. (NASDAQ: ESLT) positively. Elbit is a small, flexible company that works with industry giants such as the Boeing Co. (NYSE: BA).
Tags: astrazeneca, azn, bby, best buy, BestBuy, cadbury, cc, circuit city, CircuitCity, csg, elbit, eslt, financial times, FinancialTimes, ft, hershey, hsy, ibd, investor's business daily, Investor'sBusinessDaily, investors business daily, InvestorsBusinessDaily, london times, LondonTimes, new america, NewAmerica, newspaper, paper, periodical, tot, total, u.k. times, U.k.Times, uk times, UkTimes, wall street journal, WallStreetJournal, wrigley, wsj, wwy